Nootropic Products Should Now Become More Mainstream

As industrialized nations continue to move away from manual labor toward tech- and creative-based economies, it is about time that nootropic products become more mainstream, says Chris Miller, CEO and founder of Koios Beverage Corp., reported in NutraIngredient-usa.com.  Nootropics are drugs, supplements, and other substances that may improve cognitive function, particularly executive functions, memory, creativity, or motivation in healthy individuals, as defined by Wikipedia.

Koio’s flagship product is a canned drink with a Supplements Facts panel that touts a formula of ingredients with some scientific evidence linking them to cognitive function, such as vitamins B6 and B12, as well as proprietary blend with coconut-derived medium chain triglycerides (MCTs), L-theanine, and Lion’s Mane. 

Last month, it just landed a bricks-and-mortar distribution deal with supplement retailer GNC.  Slated for sale in around 2,700 GNC stores in the US, the company characterized it as the largest purchase order in the company’s history.  Sports and supplement retailers and distributors were early adopters’ of Koios Beverage Corp, but Chris Miller has his eyes set on more mainstream retailers as well.